CARLYLE GROUP INC
Q1 2023 Form 13-F

WASHINGTON, DISTRICT OF COLUMBIA
CIK 0001527166 · CRD 111128 · Publicly traded company
Holdings reported by AlpInvest Partners B V since Q3 2013 , TCW GROUP INC since Q2 2013
Consolidated report · includes 3 managers since Q2 2013
$3.4B Reported Value Total

THE CARLYLE GROUP reports 632 total accounts under management (AUM). There are 625 discretionary accounts valued at $192,613,890,574, and 7 non-discretionary accounts valued at $51,354,349,773.

Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
SEC Registered Discretionary & Non-Discretionary
Private funds (Form ADV)
838 funds · $228.2B gross asset value
Private Equity Fund: $148.1B · Securitized Asset Fund: $48.2B · Real Estate Fund: $31.8B · Hedge Fund: $68.8M · Other: $447.0K
Source: Form ADV filed 2026-07-07
Reported value
$3.4B
Quarter over quarter
-5.6%
Holdings
30
Top-10 concentration
96.1%

Changes are measured against the combined prior-quarter holdings of Carlyle Group Inc and Abingworth LLP (2 filings).

Reports holdings for

Holdings reported by

Key People

Form ADV owners & control persons
Kate Elizabeth Heinzelman
GENERAL COUNSEL - THE CARLYLE GROUP
Lindsay P. Lobue
CHIEF OPERATING OFFICER - THE CARLYLE GROUP
Heather Ann Mitchell
CHIEF RISK OFFICER - THE CARLYLE GROUP

Description and Activity

Carlyle Group Inc. is a global investment firm managing $426 billion in assets as of December 31, 2023. The company operates through three main business segments: Global Private Equity (GPE), Global Credit (GC), and Global Investment Solutions (GIS). The GPE segment focuses on corporate private equity, real estate, infrastructure, and natural resources, managing $161.3 billion in assets. The GC segment includes various credit strategies such as liquid credit, private credit, and real assets credit, with $187.8 billion in assets. The GIS segment offers investment opportunities through private equity fund of funds, secondary purchases, and managed co-investment programs, totaling $76.9 billion in assets.

Carlyle generates revenue primarily from management fees, performance allocations, and transaction fees associated with its investment funds. Management fees typically range from 1.0% to 2.0% of capital commitments for closed-end carry funds. Carried interest, a share of profits from investments after meeting performance thresholds, is another significant revenue stream. The company's primary customers include institutional investors, pension funds, and high-net-worth individuals. Carlyle operates globally with over 2,200 employees, including 720 investment professionals, across 28 offices. Key factors impacting Carlyle’s business performance include fundraising efforts, investment performance, and market conditions.

Company description summarized from 10-K filing.

Filing Navigation

13F Metrics

Loading 13F Metrics

Q1 2023 13F record

Q1 2023 13F filing summary

Q1 2023 Form 13F portfolio summary
Period of report March 31, 2023
Filed May 05, 2023
Form 13F-HR
Reported value $3.4B
Positions 30
Change in reported value -10.5%
New positions 2
Exited positions 4
Position turnover 17.7%
Top-10 concentration 96.1%

13F filings by quarter

Form 13F filings by quarter
Quarter Positions Value
Q2 2026 13F
Filed Aug 7, 2026
19 $10.0B
Q1 2026 13F
Filed May 8, 2026
20 $10.6B
Q4 2025 13F
Filed Feb 13, 2026
20 $13.6B
Q3 2025 13F
Filed Nov 7, 2025
17 $4.3B
Q2 2025 13F
Filed Aug 8, 2025
20 $5.0B
Q1 2025 13F
Filed May 9, 2025
23 $3.8B
Q4 2024 13F
Filed Feb 13, 2025
27 $4.1B
Q3 2024 13F
Filed Nov 8, 2024
26 $954.2M
Q2 2024 13F
Filed Aug 9, 2024
31 $1.1B
Q1 2024 13F
Filed May 3, 2024
32 $1.6B
Q4 2023 13F
Filed Feb 2, 2024
25 $2.1B
Q3 2023 13F
Filed Nov 3, 2023
25 $2.3B
Q2 2023 13F
Filed Aug 4, 2023
26 $2.8B
Q1 2023 13F
Filed May 5, 2023
30 $3.4B
Q4 2022 13F
Filed Feb 10, 2023
13 $3.4B
Q3 2022 13F
Filed Nov 10, 2022
11 $3.1B
Q2 2022 13F
Filed Aug 12, 2022
9 $5.8B
Q1 2022 13F
Filed May 13, 2022
7 $8.4B
Q4 2021 13F
Filed Feb 11, 2022
7 $9.6B
Q3 2021 13F
Filed Nov 12, 2021
10 $12.6B

33 earlier quarters on file — choose one from the quarter menu above.

Top 20 holdings · Q1 2023

Largest Q1 2023 13F positions by reported value
# Holding Reported value % of portfolio
1 QDEL Quidelortho Corp $1.1B 33.11%
2 GTM ZoomInfo Technologies Inc $905.9M 27.02%
3 MKSI MKS Instrs Inc $751.7M 22.43%
4 VTRU Vitru Ltd $142.2M 4.24%
5 GDS GDS Hldgs Ltd $76.0M 2.27%
6 PCVX Vaxcyte Inc $72.1M 2.15%
7 GETY Getty Images Holdings Inc $60.6M 1.81%
8 VRNA Verona Pharma Plc $49.3M 1.47%
9 HLVX Hillevax Inc $30.1M 0.9%
10 VERA Vera Therapeutics Inc $22.9M 0.68%
11 PHAT Phathom Pharmaceuticals Inc $20.9M 0.62%
12 JSPR Jasper Therapeutics Inc $15.8M 0.47%
13 INVH Invitation Homes Inc $14.9M 0.44%
14 RPHM Reneo Pharmaceuticals Inc $12.2M 0.37%
15 ACET Adicet Bio Inc $12.2M 0.36%
16 LSI Life Storage Inc $11.3M 0.34%
17 CUBE CubeSmart $10.2M 0.3%
18 SMHI Seacor Marine Hldgs Inc $10.0M 0.3%
19 SPRB Spruce Biosciences Inc $6.4M 0.19%
20 EM Smart Sh Global Ltd $5.3M 0.16%

Values as reported on the Q1 2023 Form 13F. Every position is in the holdings table below.

Filing Details

Loading Activities
Loading Sector Allocation
Crunching numbers

Performance

Loading Performance

Potential New Buys

Finding Potential New Buys

Holdings

Building table
Loading SEC filing data
Loading Form 4 Filings

Beneficial Ownership (Schedule 13D/13G)

Loading 13D/G filings